FDA Sounds Alarm Over State Biosimilar Drugs Bills
With California poised to regulate pharmacy substitution of biosimilars, the U.S. Food and Drug Administration on Wednesday used strong language to warn that such state-level efforts threaten to harm public confidence...To view the full article, register now.
Already a subscriber? Click here to view full article